Class I Recall of Qiagen Sciences LLC., AmniSure ROM Test
Qiagen Sciences LLC is recalling the AmniSure ROM Test due to a potential manufacturing defect causing the control line to not display. A lack of a control line may lead to misinterpretation of test results. The test is designed to display one line (control line) if the result for the presence of amniotic fluid is negative, and two lines (control line and test result line) if the result for the presence of amniotic fluid is positive. Qiagen Sciences LLC received customer complaints that some tests were not displaying a control line. Failure of a control line to appear leads to an invalid test and delay in obtaining test results due to the need of repeat testing. In addition, it is possible that the display of a test line in the absence of a control line could be misinterpreted as a negative test when it is a positive test. Inaccurate interpretation of these lab test results can lead to serious adverse events, including fetal deaths and health complications for the mother.
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
Recalled product details:
- Recalled Product(s): AmniSure Rupture of (Fetal) Membrane (ROM)
- Kit Lot Numbers: US 557016546, 5600115, and 557016547
- Test Strip Lot Number: 557014371
- Manufacturing Dates: October 20, 2017 to December 20, 2018
- Distribution Dates: October 20, 2017 to March 23, 2018
- Devices Recalled in the U.S.: 1585 Kits (39,625 Tests)
Customers are being advised to:
- Immediately discontinue use of all affected lots and return all unused product to Qiagen Sciences.
- Review the recall notice and ensure the appropriate staff is aware of the notice.
- Confirm receipt of the recall notification by completing and sending the Return Response form to Qiagen Sciences
- Direct questions to Qiagen’s Technical Services at 1-800-344-363
Health care professionals and consumers may report adverse reactions or quality problems they experience using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
Want to read the full alert and receive alert emails?